J. Cadranel, R. Gervais, M. Wislez, P. Merle, D. Moro-Sibilot, V. Westeel, L. Bigay-Game, E. A. Quoix, S. Friard, F. Barlesi, M. Zaegel, L. Moreau, I. Monnet, J. Duhamel, G. Oliviero, P. J. Souquet, L. Thiberville, L. Baudrin, F. Morin, G. Zalcman, ,
IFCT-0504 trial: Mucinous (M) and nonmucinous (NM) cytologic subtypes interaction effect in first-line treatment of advanced bronchioloalveolar carcinoma (BAC) by erlotinib (E) or carboplatin/paclitaxel (C/P). Journal of Clinical Oncology. ,vol. 29, pp. 7521- 7521 ,(2011) ,
10.1200/JCO.2011.29.15_SUPPL.7521